Carlsmed (CARL) vs ClearPoint Neuro (CLPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Carlsmed (CARL) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 5.8% versus a loss of 59.6%. Carlsmed is the larger company by market cap ($382.8 million vs $316.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | CLPT |
|---|---|---|
| Share price | $14.02 | $10.39 |
| Market cap | $382.78M | $316.79M |
| 1-day change | -2.50% | -2.58% |
| YTD return | +16.44% | -22.08% |
| 1-year return | +5.81% | -59.61% |
| 5-year return | — | -40.65% |
| EPS (TTM) | $-1.08 | $-1.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $30.10 |
| 52-week low | $8.50 | $8.27 |
| Distance from 52-week high | -18.63% | -65.50% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +36.95% | +126.29% |
| Average volume | 125.43K | 637.17K |
| Shares outstanding | 27.30M | 30.50M |
| Employees | 127 | 160 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CARL has outperformed CLPT by 65.4 percentage points over the past year.
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 160 employees
CARL vs CLPT FAQ
Which is bigger, Carlsmed or ClearPoint Neuro?
Carlsmed (CARL) is larger, with a market capitalization of $382.78M compared with $316.79M for ClearPoint Neuro (CLPT).
Which stock has performed better over the past year, CARL or CLPT?
CARL returned +5.81% over the past 12 months, compared with -59.61% for CLPT (price return, excluding dividends). Past performance does not predict future results.
Are Carlsmed and ClearPoint Neuro in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.